Initial Patient Dosed in Phase 2a Clinical Trial Evaluating First-in-Class Human Milk-Based Therapy in Patients Undergoing Stem Cell Transplantation for Blood Cancers ...Middle East

PR Newswire - News
Initial Patient Dosed in Phase 2a Clinical Trial Evaluating First-in-Class Human Milk-Based Therapy in Patients Undergoing Stem Cell Transplantation for Blood Cancers
Seeking strategic partners for continued clinical development of PBCLN-010 with PBCLN-014, a lead investigational therapy comprising human milk sugars and gut bacteria found in nursing infants Recently published data demonstrated the human milk-based treatment can safely and predictably...

Hence then, the article about initial patient dosed in phase 2a clinical trial evaluating first in class human milk based therapy in patients undergoing stem cell transplantation for blood cancers was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Initial Patient Dosed in Phase 2a Clinical Trial Evaluating First-in-Class Human Milk-Based Therapy in Patients Undergoing Stem Cell Transplantation for Blood Cancers )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News